Literature DB >> 35642539

Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

María Vallet-Regí1,2, Ferdi Schüth3, Daniel Lozano1,2, Montserrat Colilla1,2, Miguel Manzano1,2.   

Abstract

The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35642539      PMCID: PMC9252171          DOI: 10.1039/d1cs00659b

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   60.615


  637 in total

Review 1.  Mechanisms of biofilm resistance to antimicrobial agents.

Authors:  T F Mah; G A O'Toole
Journal:  Trends Microbiol       Date:  2001-01       Impact factor: 17.079

Review 2.  Nanotoxicity: the growing need for in vivo study.

Authors:  Hans C Fischer; Warren C W Chan
Journal:  Curr Opin Biotechnol       Date:  2007-12-21       Impact factor: 9.740

3.  Nanoceria-triggered synergetic drug release based on CeO(2) -capped mesoporous silica host-guest interactions and switchable enzymatic activity and cellular effects of CeO(2).

Authors:  Can Xu; Youhui Lin; Jiasi Wang; Li Wu; Weili Wei; Jinsong Ren; Xiaogang Qu
Journal:  Adv Healthc Mater       Date:  2013-04-30       Impact factor: 9.933

4.  Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole.

Authors:  Ji-Sun Lim; Kiwon Lee; Jong-Nam Choi; Yong-Kyung Hwang; Mi-Yeon Yun; Hee-Jin Kim; Yong Sun Won; Sung-Jin Kim; Hyockman Kwon; Seong Huh
Journal:  Nanotechnology       Date:  2012-02-01       Impact factor: 3.874

5.  Noninvasive Preclinical Evaluation of Targeted Nanoparticles for the Delivery of Curcumin in Treating Pancreatic Cancer.

Authors:  Prabhuraj R S; Arijit Mal; Snehal K Valvi; Rohit Srivastava; Abhijit De; Rajdip Bandyopadhyaya
Journal:  ACS Appl Bio Mater       Date:  2020-06-23

6.  A Pathogen-Specific Cargo Delivery Platform Based on Mesoporous Silica Nanoparticles.

Authors:  Bastian Ruehle; Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz; Jeffrey I Zink
Journal:  J Am Chem Soc       Date:  2017-05-05       Impact factor: 15.419

Review 7.  Mechanically interlocked molecules incorporating cucurbituril and their supramolecular assemblies.

Authors:  Kimoon Kim
Journal:  Chem Soc Rev       Date:  2002-03       Impact factor: 54.564

8.  Borate-driven gatelike scaffolding using mesoporous materials functionalised with saccharides.

Authors:  Elena Aznar; Carmen Coll; M Dolores Marcos; Ramón Martínez-Máñez; Félix Sancenón; Juan Soto; Pedro Amorós; Joan Cano; Eliseo Ruiz
Journal:  Chemistry       Date:  2009-07-13       Impact factor: 5.236

9.  A novel visible light responsive nanosystem for cancer treatment.

Authors:  M Martínez-Carmona; D Lozano; A Baeza; M Colilla; M Vallet-Regí
Journal:  Nanoscale       Date:  2017-10-26       Impact factor: 7.790

10.  Nanosilver-Decorated Biodegradable Mesoporous Organosilica Nanoparticles for GSH-Responsive Gentamicin Release and Synergistic Treatment of Antibiotic-Resistant Bacteria.

Authors:  Haijun Li; Dongbei Li; Fangman Chen; Chao Yang; Xiaogai Li; Yuan Zhang; Chunlan Hua; Xiaoxu Ma; Xin Zhao; Dan Shao; Yingshuai Wang; Liang Ming
Journal:  Int J Nanomedicine       Date:  2021-07-06
View more
  3 in total

1.  pH-Sensitive Polyacrylic Acid-Gated Mesoporous Silica Nanocarrier Incorporated with Calcium Ions for Controlled Drug Release.

Authors:  Jungwon Kong; Sung Soo Park; Chang-Sik Ha
Journal:  Materials (Basel)       Date:  2022-08-27       Impact factor: 3.748

Review 2.  Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.

Authors:  Nem Singh; Jungryun Kim; Jaewon Kim; Kyungwoo Lee; Zehra Zunbul; Injun Lee; Eunji Kim; Sung-Gil Chi; Jong Seung Kim
Journal:  Bioact Mater       Date:  2022-09-14

Review 3.  A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance.

Authors:  Guan-Jun Yang; Yan-Jun Liu; Li-Jian Ding; Fan Tao; Ming-Hui Zhu; Zhen-Yuan Shi; Juan-Ming Wen; Meng-Yao Niu; Xiang Li; Zhan-Song Xu; Wan-Jia Qin; Chen-Jie Fei; Jiong Chen
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.